2-{[(4-nitrophenyl)methyl]sulfanyl}-3-propyl-6-(trifluoromethyl)-3,4-dihydropyrimidin-4-one

Catalog No. :
ACTVSO246
CAS No. :
860609-27-4
Molecular Formula :
C15H14F3N3O3S
Molecular Weight :
373.36

IUPAC Name:2-((4-nitrobenzyl)thio)-3-propyl-6-(trifluoromethyl)pyrimidin-4(3H)-one

2-{[(4-nitrophenyl)methyl]sulfanyl}-3-propyl-6-(trifluoromethyl)-3,4-dihydropyrimidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-{[(4-nitrophenyl)methyl]sulfanyl}-3-propyl-6-(trifluoromethyl)-3,4-dihydropyrimidin-4-one
IUPAC Name2-((4-nitrobenzyl)thio)-3-propyl-6-(trifluoromethyl)pyrimidin-4(3H)-one
MDL No.MFCD04124030
Molecular FormulaC15H14F3N3O3S
Molecular Weight373.36
SMILESO=C1N(CCC)C(SCC2=CC=C([N+]([O-])=O)C=C2)=NC(C(F)(F)F)=C1
InChI KeyVQDBTPFERZLCFO-UHFFFAOYSA-N
Synonym2-{[(4-nitrophenyl)methyl]sulfanyl}-3-propyl-6-(trifluoromethyl)-3,4-dihydropyrimidin-4-one;4(3H)-Pyrimidinone, 2-[[(4-nitrophenyl)methyl]thio]-3-propyl-6-(trifluoromethyl)-
CAS No.860609-27-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTVSO246 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTVSO246 route product structure diagram
    ACTVSO246860609-27-4
Inquiry

2. ACTVSO246 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTVSO246 route product structure diagram
    ACTVSO246860609-27-4
Inquiry

Comments (0)